CoChat

The impact of Spike mutations on SARS-CoV-2 neutralization

Open access
Rees-Spear, C, Muir, L, Griffith, SA, Heaney, J, Aldon, Y, Snitselaar, JL, Thomas, P, Graham, C, Seow, J, Lee, N, Rosa, A, Roustan, C, Houlihan, CF, Sanders, RW, Gupta, R, Cherepanov, P, Stauss, H, Nastouli, E, Doores, KJ, van Gils, MJ, McCoy, LE · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
PreprintCited by 45

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Multiple SARS-CoV-2 vaccines have shown protective efficacy, which is most likely mediated by neutralizing antibodies recognizing the viral entry protein, Spike. Antibodies from SARS-CoV-2 infection neutralize the virus by focused targeting of Spike and there is limited serum cross-neutralization of the closely-related SARS-CoV. As new SARS-CoV-2 variants are rapidly emerging, exemplified by the B.1.1.7, 501Y.V2 and P.1 lineages, it is critical to understand if antibody responses induced by infection with the original SARS-CoV-2 virus or the current vaccines will remain effective against virus variants. In this study we evaluate neutralization of a series of mutated Spike pseudotypes including a B.1.1.7 Spike pseudotype. The analyses of a panel of Spike-specific monoclonal antibodies revealed that the neutralizing activity of some antibodies was dramatically reduced by Spike mutations. In contrast, polyclonal antibodies in the serum of patients infected in early 2020 remained active against most mutated Spike pseudotypes. The majority of serum samples were equally able to neutralize the B.1.1.7 Spike pseudotype, however potency was reduced in a small number of samples (3 of 36) by 5–10-fold. This work highlights that changes in the SARS-CoV-2 Spike can alter neutralization sensitivity and underlines the need for effective real-time monitoring of emerging mutations and their impact on vaccine efficacy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2021.01.15.426849

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 34

  1. Andreano, E. , Piccini, G. , Licastro, D. , Casalino, L. , Johnson, N. V. , Paciello, I. , … Rappuoli, R. (2020). SARS-CoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma. bioRxiv. · DOI · Paper page
  2. 10.1126/science.abc5902 · DOI · Paper page
  3. 10.1126/science.1225416 · DOI · Paper page
  4. 10.1016/j.cell.2020.05.025 · DOI · Paper page
  5. CDC, 2003, Update: Outbreak of severe acute respiratory syndrome--worldwide, 2003, MMWR Morb Mortal Wkly Rep, 52, 241
  6. Cevik, M. , Kuppalli, K. , Kindrachuk, J. , & Peiris, M. (2020). Virology, transmission, and pathogenesis of SARS-CoV-2. BMJ, 371. · DOI · Paper page
  7. 10.3390/v12020135 · DOI · Paper page
  8. Kemp, S. A. , Collier, D. A. , Datir, R. , Ferreira, I. A. , Gayed, S. , Jahun, A. , … Gupta, R. K. (2020). Neutralising antibodies drive Spike mediated SARS-CoV-2 evasion. medRxiv. · DOI
  9. Kidd, M. , Richter, A. , Best, A. , Mirza, J. , Percival, B. , Mayhew, M. , … McNally, A. (2020). S-variant SARS-CoV-2 is associated with significantly higher viral loads in samples tested by ThermoFisher TaqPath RT-QPCR. medRxiv. · DOI
  10. 10.1016/j.cell.2020.06.043 · DOI · Paper page
  11. 10.1038/s41586-020-2180-5 · DOI · Paper page
  12. 10.1016/j.cell.2020.07.012 · DOI · Paper page
  13. 10.1038/nature02145 · DOI · Paper page
  14. 10.1126/science.1086616 · DOI · Paper page
  15. 10.1016/j.immuni.2020.10.023 · DOI · Paper page
  16. 10.1038/s41586-020-03041-6 · DOI · Paper page
  17. Mor, M. , Werbner, M. , Alter, J. , Safra, M. , Chomsky, E. , Hada-Neeman, S. , … Freund, N. T. (2020). Multi-Clonal Live SARS-CoV-2 In Vitro Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors. bioRxiv. · DOI
  18. 10.1126/science.abe1107 · DOI · Paper page
  19. 10.1038/s41375-020-01103-2 · DOI
  20. 10.17179/excli2020-1167 · doi:10.17179/excli2020-1167 · Paper page
  21. Oude Munnink, B. B., Sikkema, R. S. , Nieuwenhuijse, D. F. , Molenaar, R. J. , Munger, E. , Molenkamp, R. , … Koopmans, M. P. G. (2020). Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans. Science. · DOI · Paper page
  22. 10.1016/S1473-3099(20)30484-9 · DOI · Paper page
  23. 10.1086/589862 · DOI · Paper page
  24. 10.1038/s41586-020-2456-9 · DOI · Paper page
  25. 10.1086/651022 · DOI · Paper page
  26. Rosa, A. , Pye, V. E. , Graham, C. , Muir, L. , Seow, J. , Ng, K. W. , … Cherepanov, P. (2021). SARS-CoV-2 recruits a haem metabolite to evade antibody immunity. In preparation. · DOI
  27. 10.1016/j.cell.2020.08.012 · DOI · Paper page
  28. 10.7554/eLife.61312 · DOI · Paper page
  29. 10.1093/ve/veaa094 · DOI
  30. 10.1371/journal.ppat.1009089 · DOI
  31. Xie, X. , Zou, J. , Fontes-Garfias, C. R. , Xia, H. , Swanson, K. A. , Cutler, M. , … Shi, P.-Y. (2021). Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera. bioRxiv. · DOI · Paper page
  32. Xu, C. , Wang, Y. , Liu, C. , Zhang, C. , Han, W. , Hong, X. , … Cong, Y. (2021). Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM. Science Advances, 7. · DOI · Paper page
  33. 10.1038/s41423-020-0458-z · DOI · Paper page
  34. 10.1093/infdis/jiy696 · DOI

Cited by

See all 45

Metadata

Authors
Rees-Spear, C., Muir, L., Griffith, S., Heaney, J., Aldon, Y., Snitselaar, J., Thomas, P., Graham, C., Seow, J., Lee, N., Rosa, A., Roustan, C., Houlihan, C., Sanders, R., Gupta, R., Cherepanov, P., Stauss, H., Nastouli, E., Doores, K., van Gils, M., & McCoy, L.
Venue
bioRxiv (Cold Spring Harbor Laboratory)
Publisher
openRxiv
Published
2021-01-19
OpenAlex
W3122275632
Cited by
45
References
11
Type
posted content
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The impact of Spike mutations on SARS-CoV-2 neutralization. https://app.cochat.ai/papers/10.1101/2021.01.15.426849
The paper
Rees-Spear, C., Muir, L., Griffith, S., Heaney, J., Aldon, Y., Snitselaar, J., Thomas, P., Graham, C., Seow, J., Lee, N., Rosa, A., Roustan, C., Houlihan, C., Sanders, R., Gupta, R., Cherepanov, P., Stauss, H., Nastouli, E., Doores, K., . . . McCoy, L. (2021). The impact of Spike mutations on SARS-CoV-2 neutralization. bioRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.1101/2021.01.15.426849

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.